Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.0080
+0.0010 (14.29%)
Mar 11, 2026, 4:10 PM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 76.13 million as of March 11, 2026. Its market cap has increased by 3.96% in one year.
Market Cap
76.13M
Enterprise Value
27.03M
Revenue
6.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 76.13M, an increase of 47.79%. That is a compound annual growth rate of 1.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 76.13M | -12.50% |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 114.21M |
| Arovella Therapeutics | 91.14M |
| LTR Pharma | 83.62M |
| Radiopharm Theranostics | 81.52M |
| Cynata Therapeutics | 77.17M |
| Imugene | 73.95M |
| Prescient Therapeutics | 62.04M |
| Neurizon Therapeutics | 58.68M |